European observational study SANTORINI shows LDL-C levels remain higher than recommended goals and combination therapies are under-utilised in patients at very high or high cardiovascular risk
Our goal is to help reduce CV risk for high- and very-high risk patients and, ultimately, reduce the impact of cardiovascular disease for people and healthcare systems across Europe.
- Our goal is to help reduce CV risk for high- and very-high risk patients and, ultimately, reduce the impact of cardiovascular disease for people and healthcare systems across Europe.
- The study population consists of high- and very high-risk patients previously diagnosed and treated as well as newly diagnosed and requiring treatment.
- To facilitate accurate recording of data, patients can optionally fill in a memory aid to note important details.
- Treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe: baseline demographics from the multinational observational SANTORINI study.